ID: ALA4544167

Max Phase: Preclinical

Molecular Formula: C17H9BrN4OS2

Molecular Weight: 429.32

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  N#Cc1ccccc1Nc1sc(C(=O)c2ccc(Br)s2)c(N)c1C#N

Standard InChI:  InChI=1S/C17H9BrN4OS2/c18-13-6-5-12(24-13)15(23)16-14(21)10(8-20)17(25-16)22-11-4-2-1-3-9(11)7-19/h1-6,22H,21H2

Standard InChI Key:  VHURFYAJIJCIIX-UHFFFAOYSA-N

Associated Targets(Human)

Maternal embryonic leucine zipper kinase 3491 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 429.32Molecular Weight (Monoisotopic): 427.9401AlogP: 4.87#Rotatable Bonds: 4
Polar Surface Area: 102.70Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.91CX Basic pKa: CX LogP: 5.33CX LogD: 5.33
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.58Np Likeness Score: -1.87

References

1. Boutard N, Sabiniarz A, Czerwińska K, Jarosz M, Cierpich A, Kolasińska E, Wiklik K, Gluza K, Commandeur C, Buda A, Stasiowska A, Bobowska A, Galek M, Fabritius CH, Bugaj M, Palacz E, Mazan A, Zarębski A, Krawczyńska K, Żurawska M, Zawadzki P, Milik M, Węgrzyn P, Dobrzańska M, Brzózka K, Kowalczyk P..  (2019)  5-Keto-3-cyano-2,4-diaminothiophenes as selective maternal embryonic leucine zipper kinase inhibitors.,  29  (4): [PMID:30626559] [10.1016/j.bmcl.2018.12.051]

Source